News

BioPhotas, Inc. Unveils the Innovative Celluma Series 2 DELUX

BioPhotas, Inc. Unveils the Innovative Celluma Series 2 DELUX

Introducing the Celluma Series 2 DELUX

BioPhotas, Inc. has made waves in the world of light therapy with its latest product innovation, the Celluma Series 2 DELUX. This device is not just an addition; it represents a significant leap forward in the field of LED therapy solutions for both professionals and personal users. What sets this device apart? It’s the world’s first full-body light therapy device with four FDA-cleared treatment modes: body contouring, acne, pain relief, and fine lines, all in one unit.

The Evolution of Celluma

The Series 2 DELUX evolves from the successful Series 1 offerings, merging the capabilities of previous models into a single device. Customers now enjoy the flexibility of four advanced treatment options without having to make compromises about which benefits they want to include. It’s a game changer in the therapy market, offering cutting-edge technology at a price point that remains accessible.

Design and Functionality

This newest model stays true to BioPhotas' commitment to quality and user satisfaction. The DELUX S2 is designed with renewed durability and enhanced capabilities, including a new digital display timer for treatments and easy functionality for pausing and resuming sessions. Customers can select between two sizes, ensuring that it fits seamlessly into their lives and spaces.

Target Market and Pricing

With a pricing structure of $9,995 for the Regular model and $14,995 for the XL, the Series 2 DELUX offers incredible value compared to alternatives like LED treatment beds or infrared saunas. Its compact design and versatility make it perfect for home use, allowing families to benefit from top-tier light therapy without needing an entire room dedicated to treatment.

Combination with PRO PLUS

The pairing of the DELUX S2 with the Celluma PRO PLUS enhances the user's experience by providing a more comprehensive light therapy solution. Customers who buy this combination save significantly, making it a smart investment for those looking to improve their wellness treatments at home.

Customer Feedback and Anticipation

Already, feedback for the DELUX has been overwhelmingly positive, with many praising its efficiency and user-friendly design. The announcement has sparked excitement among users who appreciate having an all-in-one solution for light therapy needs.

About BioPhotas, Inc.

Based in Tustin, California, BioPhotas, Inc. is recognized as a leading manufacturer of LED light therapy devices. Their products not only cater to aesthetic and medical professionals but also empower individual users to utilize light therapy in their homes efficiently. With a dedication to health and wellness through innovative treatments, BioPhotas serves customers across more than 85 countries, creating a positive impact globally.

BioPhotas, Inc. firmly believes in the power of LED technology to boost overall well-being, making it a trusted name in the industry.

Frequently Asked Questions

What is the Celluma Series 2 DELUX?

The Celluma Series 2 DELUX is a full-body LED light therapy device with four FDA-cleared treatment modes.

How does the Series 2 DELUX work?

It utilizes biophotonic technology to deliver various wavelengths of light that promote healing and rejuvenation in the skin.

What are the benefits of the DELUX S2?

It offers treatments for body contouring, acne, pain relief, and anti-aging, combining four effective therapies into one device.

Is it suitable for home use?

Yes, the compact design makes it easy to store and use at home, making professional-quality therapy accessible to individuals.

What is the price of the Celluma Series 2 DELUX?

The retail price is $9,995 for the Regular version and $14,995 for the XL.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 324

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 256

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 169

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 138

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 102

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 144

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 232

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 94

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

Replicate Bioscience Advances Innovative Vaccine Technology

Updated Category News Views 183

Replicate Bioscience Announces Innovative Vaccine Progress Replicate Bioscience is breaking new ground with its srRNA vaccine candidate, RBI-4000, aiming to tackle rabies through pioneering technology. Recent findings from the Phase I trial emphasize the promising durability of this vaccine, laying the groundwork for a potential breakthrough in global health. Key Findings...

Continue Reading
China's Financial Markets Thrive Amid Global Challenges

Updated Category News Views 161

China's Financial Markets Exhibit Remarkable Resilience China's financial markets have shown impressive resilience, with the benchmark Shanghai Composite Index surging past 3,300 during active trading sessions. Recent trends reveal that both onshore and offshore yuan appreciated against the US dollar, now stabilizing around the 7.2 mark. Positive Policy Changes Support...

Continue Reading
Robert Kiyosaki's Call for Financial Readiness Amid Economic Turmoil

Updated Category News Views 556

Understanding Robert Kiyosaki's Recent Predictions Robert Kiyosaki, the well-known financial educator and author, has issued a stark warning about the future of the economy. He believes that a significant market crash is on the horizon, along with widespread layoffs. Rather than ignoring these warnings, Kiyosaki urges individuals to prepare proactively for the challenges...

Continue Reading
The Unstoppable Rise of Netflix: A Stock to Watch

Updated Category News Views 184

Netflix's Remarkable Stock Journey It may sound surprising that a stock can still be considered irresistible after a staggering 350% increase, especially when it recently reached a new high. However, it’s hard not to feel optimistic about Netflix, Inc (NASDAQ: NFLX). This company, which once experienced a dramatic drop of 80% in its stock value just two years ago, has...

Continue Reading
Declining Oil Prices Amid Rising Fuel Inventories in the U.S.

Updated Category News Views 156

Oil Prices Experience Additional Declines Recent movements in oil prices have showcased a downward trend, influenced mostly by increasing fuel inventories in the U.S. This change came as a surprise to some analysts, who expected a different outcome. Impact of U.S. Fuel Inventories The latest reports indicate a significant rise in U.S. fuel stocks. This update has had a...

Continue Reading